Traduction de «swedish » (Néerlandais → Français) :

Swedish Orphan Biovitrum International AB SE-112 76 Stockholm Zweden
Swedish Orphan Biovitrum International AB SE-112 76 Stockholm Suède

Norge Swedish Orphan Biovitrum AS Østensjøveien 18, Bryn N-0661 OSLO Tlf: + 47 66 82 34 00 mail.no@sobi.com
Magyarország Valeant Pharma Magyarország Kft. Csatárka u. 82-84, H-1025 Budapest Hungary Tel: +36-1-345-5900 Fax: +36-1-345-5918

Swedish Orphan Biovitrum AB (publ) Strandbergsgatan 49 SE-11276 Stockholm Zweden
Swedish Orphan Biovitrum AB (publ) Strandbergsgatan 49 SE-11276 Stockholm Suède

Schwan S, Sundstrom A, Stjernberg E, Hallberg E, Hallberg P. A signal for an abuse liability for pregabalin‐‐results from the Swedish spontaneous adverse drug reaction reporting system.
Schwan S, Sundstrom A, Stjernberg E, Hallberg E, Hallberg P. A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system.

17. Larsson LG, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, et al. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
17. Tabar L, Dean PB, Kaufman CS, Duffy SW, Chen HH. A new era in the diagnosis of breast cancer.

Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Olesen JB, Lip GYH, Hansen ML et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.

52. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials.
51. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials.

An initiative started by the Novartis Foundation for Sustainable Development with Swiss and Swedish development agencies provides support to the Regional Psychosocial Support Initiative (REPSSI), which helps children affected by HIV/AIDS, poverty and conflict in 13 African countries.
En association avec deux organismes d’aide au développement suisse et suédois, la Fondation Novartis pour un développement durable permet de soutenir le projet REPSSI (Regional Psychosocial Support Initiative), lequel vient en aide aux enfants touchés par le sida, la pauvreté ou la guerre dans treize pays africains.

Houder van de vergunning voor het in de handel brengen en fabrikant Swedish Orphan Biovitrum International AB SE-112 76 Stockholm Zweden
Titulaire de l'Autorisation de mise sur le marché : Swedish Orphan Biovitrum International AB SE-112 76 Stockholm Suède

Overige informatie over Orfadin: De Europese Commissie heeft op 21 februari 2005 een in de hele Europese Unie geldige vergunning voor het in de handel brengen van Orfadin verleend aan Swedish Orphan International AB.
Autres informations relatives à Orfadin: La Commission européenne a délivré une autorisation de mise sur le marché valable dans toute l’Union européenne pour Orfadin à Swedish Orphan International AB, le 21 février 2005.